News for hackers. Stuff that matters.

A comment on Mylan’s EpiPen price hike was a scheme to stifle competition, rival claims. Parent comment

Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by scaryspooky on Wednesday April 26, 2017 @09:57AM (#14202961)
Except there is very little "free market" about the medical device industry, which is heavily regulated and also able to abuse the patent system.
[ Parent | on HN ]
Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by cmdrfred on Wednesday April 26, 2017 @10:03AM (#14203006)
Probably the most regulated market we have.
[ Parent | on HN ]
Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by Symmetry on Wednesday April 26, 2017 @10:41AM (#14203359)
Drugs combine the intensive quality regulations that medical devices have with production quotas so those probably edge out medical devices.
[ Parent | on HN ]
Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by cmdrfred on Wednesday April 26, 2017 @02:52PM (#14205863)
Isn't this a medical device that contains a drug?
[ Parent | on HN ]